Cited by 410Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 37 of the 39 references it cites were found in a registry or an index.

Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease

Braak, H, Braak, E·1997·Neurobiology of Aging

DOI 10.1016/s0197-4580(97)00062-6

Open this paper in CoChat — free account

Abstract

Prior to any evaluation of morphologic brain changes, a decision must be made whether a given alteration is associated with aging or with disease. Patients with disease-related lesions may be in a clinically silent phase of a disease or show overt symptoms. Neurofibrillary tangles and neuropil threads are the hallmarks of Alzheimer's disease. They should not be considered to be age-related changes, even when they are present only in small numbers. In general, the initial changes consist of neurofibrillary tangles and neuropil threads. Plaques (amyloid deposits and/or neuritic plaques) are consistently present in the end stage of the disease. Initial neurofibrillary tangles and neuropil threads develop at specific cortical predilection sites. The changes then spread in a predictable, nonrandom manner across other portions of the telencephalic cortex. The sequential changes in the distribution pattern of the lesions provide the basis for a staging procedure that takes the slow and gradual progression of the destructive process into consideration. The staging procedure provides accurate diagnoses in the initial stages and even reveals brain changes developing prior to the appearance of clinical symptoms. It is thus advantageous in characterizing nondemented controls. The staging procedure can be carried out easily and does not require knowledge of clinical data, quantitative assessments, or adjustments for the age of the patients. Application of advanced silver techniques (Gallyas, Campbell-Switzer) to demonstrate Alzheimer's disease-related lesions also allows recognition of the hallmarks of other disorders, such as Lewy body disease (Parkinson's disease) and dementia with argyrophilic grains, which frequently co-occur with Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1016/s0197-4580(97)00062-6

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citation
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G., & Heyman, A. (2002) · doi:10.1002/0470846410.ch42(iii · Cited by 2,859
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads
Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769
Self-citation
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 752
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721
The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings
Albert Hofman, D., Rocca, W. A., Brayne, C., Breteler, M. M. B., Clarke, M., Cooper, B. K., Copeland, J. R. M., Dartigues, J. F., Droux, A. D. S., Hagnell, O., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.3.736 · Cited by 667

Show all 39 references

Research works printed but not linked: 1

Duyckaerts, 1994, Diagnosis and staging of Alzheimer’s disease in a prospective study involving aged individuals, Neurobiol. Aging, 15, 140

Sorted by citations

Items 301–400 of 409

Are routine methods good enough to stain senile plaques and neurofibrillary tangles in different brain regions of demented patients?
Mavrogiorgou, P., Gertz, H., Ferszt, R., Wolf, R. J., Bär, K., & Juckel, G. (2011) · PubMed · Cited by 8
THE COMBINATION OF SILVER TECHNIQUES FOR STUDYING THE PATHOLOGY OF ALZHEIMER'S DISEASE
Tsamis, K. I., Mytilinaios, D. G., Njau, S. N., Psaroulis, D., MAVROUDIS, J., Costa, V., & Balogiannis, S. (2008) · International Journal of Neuroscience · doi:10.1080/00207450701591115 · Cited by 8
Bionic Microtubules: Potential Applications to Multiple Neurological and Neuropsychiatric Diseases
Woolf, N. (2009) · Journal of Nanoneuroscience · doi:10.1166/jns.2009.009 · Cited by 10
“In the early stages of Alzheimer’s disease, neurofibrillary tangles outstrip senile plaques; both neurofibrillary tangles and senile plaques are abundant in more advanced stages of the disease (Braak and Braak, 1997).”
Background
PET Imaging in Alzheimer Disease in the Era of Antiamyloid Therapy in the United States: Clinical Utility, Quantification, and Policy Landscape
Skyles, T. J., Bouchal, S. M., Giarratana, A. O., Wengler, J., Hart, I. R., Greig, E. E., Singh, H., Huang, S. S., Martinez, F., Nguyen, B. D., et al. (2026) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.125.271835 · Cited by 9
Postmortem imaging and neuropathologic correlations
Augustinack, J. C., & van der Kouwe, A. J. W. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53486-6.00069-7 · Cited by 7
Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer’s Disease from Age-Matched Controls
Greco, F. A., McKee, A. C., Kowall, N. W., & Hanlon, E. B. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201021 · Cited by 6
“NIA-Reagan criteria [34] and Braak neurofibrillary staging [35] were tabulated.”
BackgroundMethod
Computer Aided Diagnosis of Alzheimer Disease Using Support Vector Machines and Classification Trees
Salas-Gonzalez, D., Górriz, J. M., Ramı́rez, J., López, M., Álvarez, I., Segovia, F., & Puntonet, C. G. (2009) · Lecture notes in computer science · doi:10.1007/978-3-642-03040-6_51 · Cited by 7
Purkinje Cell Loss in Essential Tremor: Collective Data From 215 Brains Over a 21‐Year Period
Kerridge, C. A., Hernandez, R. S., Hernandez, N. C., Faust, P. L., & Louis, E. D. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70204 · Cited by 6
Computer assisted diagnosis of Alzheimer’s disease using statistical likelihood-ratio test
Zheng, X., Cawood, J., Hayre, C. M., Wang, S., & for the Alzheimer’s Disease Neuroimaging Initiative Group (2023) · PLoS ONE · doi:10.1371/journal.pone.0279574 · Cited by 6
Genetic influences on white matter and metabolism abnormal change in Alzheimer’s disease: Meta-analysis for neuroimaging research on presenilin 1 mutation
Gu, X., Chu, T., Liu, L., & Han, X. (2018) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2018.12.016 · Cited by 6
Positron Emission Tomography in Alzheimer Disease
Schmidt, M. E., Matthews, D. C., Andrews, R. D., & Mosconi, L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00005-6 · Cited by 7
Investigating the cognitive enhancement effects of multisensory VR reminiscence therapy on older adults: Analyzing the impact of sensory combinations
Lee, I.-J., & Pan, X.-T. (2025) · Computers in Human Behavior · doi:10.1016/j.chb.2025.108668 · Cited by 5
Cognitive Reserve
Varangis, E. M. L., & Stern, Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108552684.003 · Cited by 7
Screening for Small Molecule Inhibitors of Statin-Induced APP C-terminal Toxic Fragment Production
Poksay, K. S., Sheffler, D. J., Spilman, P. R., Campagna, J. J., Jagodzinska, B. M., Descamps, O., Gorostiza, O. F., Matalis, A., Mullenix, M. C., Bredesen, D. E., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00046 · Cited by 5
“This C-terminal APP proteolytic cleavage is markedly increased in early stages of AD as related to Braak staging (Braak and Braak, 1997); increased staining is seen in the hippocampal region and around some plaque and tangle-like structures as well as in periand intra- neuronal regions of AD…”
Background
Infectious complications of hip arthroplasty
Pidhaietskyi, V. M., Gayko, G. V., Kozak, R. A., & Nizalov, T. V. (2021) · International Journal of Health Sciences · doi:10.53730/ijhs.v5n3.1520 · Cited by 5
Decreased Synaptic Vesicle Glycoprotein 2A Binding in the Human Postmortem Essential Tremor Cerebellum: Evidence of Reduction in Synaptic Density
Yang, Y., Zheng, C., Chen, B., Hernandez, N. C., Faust, P. L., Cai, Z., Louis, E. D., & Matuskey, D. (2023) · The Cerebellum · doi:10.1007/s12311-023-01611-8 · Cited by 5
“Braak and Braak Alzheimer’s disease staging for neurofibrillary tangles and CERAD (The Consortium to Establish a Registry for Alzheimer's Disease) stage for neuritic plaques were assigned [59, 60].”
PET Imaging of Epigenetic Influences on Alzheimer’s Disease
Couto, P. J., & Millis, R. M. (2015) · International Journal of Alzheimer's Disease · doi:10.1155/2015/575078 · Cited by 19
Better Utilization of Mouse Models of Neurodegenerative Diseases in Preclinical Studies: From the Bench to the Clinic
Janus, C., Hernandez, C., deLelys, V., Roder, H. M., & Welzl, H. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3661-8_18 · Cited by 4
Distinct Effects of the Apolipoprotein E ε4 Genotype on Associations Between Delayed Recall Performance and Resting-State Electroencephalography Theta Power in Elderly People Without Dementia
Wang, J., Sun, T., Zhang, Y., Yu, X., & Wang, H. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.830149 · Cited by 4
“…of the disease might be more important (Smailovic et al., 2018), since left hemisphere metabolic activity appears to be affected earlier than right hemisphere metabolic activity Frontiers in Aging Neuroscience | www.frontiersin.org 5 May 2022 | Volume 14 | Article 830149 (Braak and Braak, 1997).”
Background
Altered properties of amyloidogenic prion protein in genetic Creutzfeldt–Jakob disease with PRNP V180I mutation in response to pentosan polysulfate
Shijo, M., Yoshimura, M., Omae, T., Hashimoto, G., Mizoguchi, T., Kuwashiro, T., Komori, T., Tsuboi, Y., Saito, T., Nakagawa, M., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13197 · Cited by 4
“The assessment of Alzheimer’s disease pathology was performed according to the CERAD (Consortium to Establish a Registry for Alzheimer’s Disease) guidelines [23], Braak and Braak stage [24, 25], and Thal scores [26].”
Method
Is neurocardiovascular instability a risk factor for cognitive decline and/or dementia? The science to date
Collins, O., & Kenny, R. A. (2007) · Reviews in Clinical Gerontology · doi:10.1017/s0959259808002529 · Cited by 4
HSV1 in Alzheimer’s disease: Myth or reality?
Špeljko, T., Jutrić, D., & Šimić, G. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0009-2 · Cited by 4
Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics
Bibl, M., & Wiltfang, J. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.2.153 · Cited by 4
14‐3‐3σ up‐regulation in the temporal cortex associates with tau pathology and reactive astroglia in Lewy body disorders
Marsal-García, L., Mena, J., Lao, C., Adamuz, D., Arnaldo, L., Carrato, C., Albarracín, A. M., Samaniego, D., Vilas, D., Ispierto, L., et al. (2025) · Brain Pathology · doi:10.1111/bpa.70059 · Cited by 3
“The presence and distribution of AS-related and AD-type pathology were assessed following the corresponding criteria by Braak et al. [29], and Braak and Braak [4], respectively.”
Segmentation ciblée d’images IRM et maladie d’Alzheimer
Marie Chupin, A., Gérardin, E., Cuingnet, R., Bardinet, É., Dormont, D., Colliot, O., & Garnero, L. (2011) · IRBM · doi:10.1016/j.irbm.2011.01.003 · Cited by 3
Pathologies Responsible for the Development of the Neurogenic Bladder
Corcos, J., & Przydacz, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-63910-9_3 · Cited by 3
Clinical Analysis of the Diagnostic Classification of Geriatric Disorders
Patrizi, G., Patrizi, G., Cioccio, L. D., & Bauco, C. (2007) · Springer optimization and its applications · doi:10.1007/978-0-387-69319-4_14 · Cited by 3
Functional Magnetic Resonance Imaging (fMRI) in the Classroom
Rosen, A. C. (2009) · The American Journal of Bioethics · doi:10.1080/15265160802617936 · Cited by 3
Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer’s Disease
Bengoetxea, X., de Ceráin, A. L., Azqueta, A., & Ramírez, M. J. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160636 · Cited by 3
“Neuropathologically, AD brain is characterized by the accumulation of neurofibrillary tangles and senile plaques [1, 2].”
Integrating Data for Modeling Biological Complexity
Hunter, S., & Brayne, C. (2013) · Springer eBooks · doi:10.1007/978-3-642-30574-0_52 · Cited by 3
Reaching a Diagnosis of a Dementia Subtype
Chui, H. C., Lee, A., Cummings, J. L., Tierney, M. C., Payami, H., Guzmán, J. D., Maríamillán, J., Muñoz, D. G., Bermejo, F., Bosscher, L., et al. (2003) · Wiley eBooks · doi:10.1002/9780470752340.ch16 · Cited by 3
Predicting Cognitive Decline for Non-Demented Adults with High Burden of Tau Pathology, Independent of Amyloid Status
Wu, H.-S., Li, L., Sun, Q.-Q., Tan, C.-C., Tan, L., & Xu, W. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.82 · Cited by 2
Siamese Graph Convolutional Network quantifies increasing structure-function discrepancy over the cognitive decline continuum
Gamgam, G., Yıldırım, Z., Kabakçıoğlu, A., Gurvit, H. I., Demıralp, T., & Acar, B. (2024) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2024.108290 · Cited by 4
Mettre la maladie d’Alzheimer en images
Pariente, J., Payoux, P., Querbes, O., Barbeau, E. J., Puel, M., Chollet, F., & Démonet, J. (2009) · NPG. Neurologie, psychiatrie, gériatrie/NPG · doi:10.1016/j.npg.2009.06.001 · Cited by 2
Imaging Biomarkers for Diagnosis, Prognosis and Treatment of Alzheimer's Disease
Skovronsky, D., & Feuerstein, G. (2012) · Frontiers in neuroscience · doi:10.1201/b11986-4 · Cited by 2
Diagnostic utility and characteristics of CT-based attenuation correction in brain perfusion SPECT/CT in predicting the exacerbation of Alzheimer changes from mild cognitive impairment utilizing voxel-based statistical analysis in comparison with Chang’s method
Sohara, K., Kiriyama, T., Mizumura, S., Ishiwata, A., Yamazaki, M., Kimura, K., & Kumita, S. (2020) · Annals of Nuclear Medicine · doi:10.1007/s12149-020-01477-4 · Cited by 2
Epigenetic regulons in Alzheimer's disease
Raval, M., Mishra, S., & Tiwari, A. K. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.01.012 · Cited by 2
Distinct neuronal vulnerability and metabolic dysfunctions are characteristic features of fast-progressing Alzheimer's patients with Lewy bodies
Rahman, M., Sharma, P., Chattopadhyay, T., & Saroja, S. R. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108396 · Cited by 2
“Tau accumulation begins in the entorhinal cortex, followed by limbic regions, and subsequently spreads across the neocortical areas, leading to progressive cognitive decline (3, 5).”
Collinge et al. reply
Collinge, J., Jaunmuktane, Z., Mead, S., Rudge, P., & Brandner, S. (2016) · Nature · doi:10.1038/nature18603 · Cited by 2
Alzheimer's Disease
Knopman, D. S., Ritchie, K. A., Polge, C., Alafuzoff, I. I., & Soininen, H. S. (2003) · Wiley eBooks · doi:10.1002/9780470752340.ch19 · Cited by 2
Why delay in effective treatment for Alzheimer's disease and related conditions
Iqbal, K., Liu, F., Gong, C., Dai, C., & Hu, W. H. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.08.002 · Cited by 1
Tau Pathology in Alzheimer's Disease: Bridging Molecular Mechanisms and Targeted Therapies
Dahiya, M., Yadav, M., Kumar, A., & Goyal, C. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273376581250626003322 · Cited by 2
AAV-mediated peripheral scFv's administration to reduce cerebral tau in adult P301S transgenic mice: Mono-vs. combination therapy
Katel, S., Cicalo, J., Vasciaveo, V., Vecchio, L. M., Carrión, J., Leann, M., Huerta, P. T., Choksi, J. D., Aubert, I., Marambaud, P., et al. (2025) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2025.101563 · Cited by 2
Cognitive tests distinguish biomarker-verified early Alzheimer’s disease from other patients
Kiene, F., Notbohm, A., Roheger, M., Duning, T., & Hildebrandt, H. (2026) · BMC Neurology · doi:10.1186/s12883-026-04742-7 · Cited by 1
Is there a cognitive measure of neurodegeneration for amyloid-Aβ-ratio probable Alzheimer's disease patients?
Hildebrandt, H., Duning, T., & Holland-Letz, M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261444308 · Cited by 1
Diagnostic précoce de la maladie d’Alzheimer
Saint‐Aubert, L., Puel, M., Chollet, F., & Pariente, J. (2012) · Revue Neurologique · doi:10.1016/j.neurol.2012.07.006 · Cited by 4
Evidence for an Infectious Etiology in Alzheimer’s Disease
Balin, B. J., Hammond, C. J., Scott, C., Appelt, D. M., & Hingley, S. T. (2011) · InTech eBooks · doi:10.5772/29247 · Cited by 1
Present and future of the Tau dementia therapy
Takashima, A. (2013) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.53.1040 · Cited by 1
Neurodegenerative disorders
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.030 · Cited by 1
Models of Alzheimer’s Disease
Chen, M., Kretzschmar, D., Verdile, G., & Lardelli, M. T. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00025-7 · Cited by 2
Collinge et al. reply
Collinge, J., Jaunmuktane, Z., Mead, S., Rudge, P., & Brandner, S. (2016) · Nature · doi:10.1038/nature19087 · Cited by 1
Dysfunctional Bladder Morphology and Functional Impairments Are Identified in the Alzheimer’s Disease APPNL-G-F/NL-G-F Murine Model
Ge, Y., AlObaidi, A. S., Kuchel, G. A., Bartley, J. M., Smith, P. P., He, W., & Hu, X. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230547 · Cited by 1
A new neuroprotective candidate TJ1 targeting amyloidogenesis in 5xFAD Alzheimer’s disease mice
Deng, J., Huang, L.-F., Bian, Z.-Y., Feng, X.-Y., Qi, R.-Y., Dong, W.-X., Gao, J., & Tang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112653 · Cited by 1
3 Neuropathology of Aging
Dickstein, D. L., Morrison, J. H., & Hof, P. R. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0003 · Cited by 2
A “Stress Test” of the 2018 NIA AA Research Criteria for Alzheimer’s Disease
Hildebrandt, H., Kastrup, A., & Eling, P. (2020) · Zeitschrift für Neuropsychologie · doi:10.1024/1016-264x/a000281 · Cited by 1
Dementia and bladder dysfunction: a focus on treatments with anticholinergics
Sakakibara, R., & Tateno, F. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815946-0.00014-4 · Cited by 1
Impact of the New Conceptual Framework of Alzheimer’s Disease in Imaging Studies
Dubois, B., Villain, N., Jacova, C., & Uspenskaya, O. (2020) · Springer eBooks · doi:10.1007/978-3-030-53168-3_13 · Cited by 1
Aktuelle Entwicklungen der strukturellen MRT zur Frühdiagnostik der Alzheimer-Demenz
Ewers, M., Teipel, S. J., & Hampel, H. J. (2005) · Nervenheilkunde · doi:10.1055/s-0038-1629942 · Cited by 1
A novel method for identification of candidate genes for Alzheimer’s disease using network topology measure and intelligent based deep learning modelsPreprint
Sundar, G. N., Narmadha, D., Ramasamy, M. D., Loganathan, A. K., Muthusamy, S., Panchal, H. N., Thangaraj, K., & Ravindaran, A. K. (2022) · Research Square · doi:10.21203/rs.3.rs-1860248/v1 · Cited by 1
The Alzheimer Disconnectome
Brodtmann, A. G., & Beversdorf, D. Q. (2023) · Neurology · doi:10.1212/wnl.0000000000207303 · Cited by 1
AAV-mediated peripheral single chain variable fragments’ administration to reduce cerebral tau in adult P301S transgenic mice: mono- vs combination therapyPreprint
Katel, S., Cicalo, J., Vasciaveo, V., Carrión, J., Leann, M., Huerta, P. T., Marambaud, P., Giliberto, L., & d’Abramo, C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.13.638144 · Cited by 1
Biomolecular studies in Alzheimer’s Disease models: investigations in vitro and in vivo
Lattanzio, F. (2013) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/5507
“The hippocampus and entorhinal cortex are brain structures involved in memory formation and firstly impaired during early neurodegenerative processes of AD (Braak and Braak, 1997).”
Background
Poliformismos do gene da proteína príon celular em pacientes com doença de Alzheimer
Smid, J. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-24052011-142607
Memory, genes, and brain imaging : relating the APOE gene to brain function and structure
Lind, J. (2007) · Figshare
Regulation of the kinase MARK from Rattus norvegicus (Berkenhout, 1769): activation by MARKK and inhibition by PAK5
Li, X. (2006)
Enfermedad de Alzheimer de inicio presenil esporádica: Caracterización clínico-biológica y diagnóstico precoz
Balasa, M. (2013) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Interactive mechanism between beta-amyloid process, alfa7 nicotinic receptor, glial cell activation and oxidative stress in Alzheimer's disease
Yu, W. (2006) · Figshare
Symposium Overview
Murphy, C. A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04492.x
Frontotemporal dementia with ubiquitinated inclusions: A case study of the regional distribution of hippocampal pathology
Mehring, B., Lin, J. C. Y., Wilson, D., & Lippa, C. F. (2000) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750001500507
Male incontinence: Evaluation and treatment
Padmanabhan, P., & Milam, D. F. (2009) · Current Bladder Dysfunction Reports · doi:10.1007/s11884-009-0021-3
“The pathologic hallmarks include senile plaques and neurofi brillary tangles initially appearing in the orbitotemporal cortices [ 36 ].”
Background
Neuroimaging Studies in Alzheimer's Disease
Cuellar, H., Gómez‐Ramos, P., Riascos, R., & Alba, L. D. (2009) · The Neuroradiology Journal · doi:10.1177/197140090902200503
Cerebrospinal fluid markers for the early and differential diagnosis of Alzheimer's disease
Schoonenboom, S. N. M. (2006) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam)
Cerebrovascular contributions to amnestic mild cognitive impairment
DeCarli, C. S., Mayda, A. B. V., & Nordahl, C. W. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.012
La melatonina: un coadyuvante potencial en el tratamiento de las demencias
Jiménez-Rubio, G., Ugalde, Ó., Ortíz‐López, L., Ramírez-Rodríguez, G. B., & Benítez‐King, G. (2008) · Redalyc (Universidad Autónoma del Estado de México)
Abeta Predictor of Alzheimer Disease Symptoms
Sephton, C. F., & Yu, G. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.875
Evaluation of cognitive performance within the disease course of Alzheimers
Neuropsychology, M. T. (2013)
Brief Report Cerebellar Pathology of a Dual Clinical Diagnosis: Patients with Essential Tremor and Dystonia
Ma, K., Babij, R., Vonsattel, J., & Louis, E. D. (2012)
Phosphodiesterase 5 inhibition on dopaminergic and glutamatergic neurotransmission: Implications for memory ehancement
Uthayathas, S. (2009)
[Brain aging and insulin signals].
Takashima, A. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.125.137
Disambiguating the Similar: Investigating Pattern Separation in Medial Temporal Lobe Structures Using Rodent Models
Kent, B. A. (2015) · Apollo (University of Cambridge) · doi:10.17863/cam.16474
CREB-mediated Enhancement of Hippocampus-dependent Memory Consolidation and Reconsolidation
Sekeres, M. J. (2012) · TSpace (University of Toronto)
Alzheimer-Demenz und andere degenerative Demenzen
Förstl, H., Bickel, H., & Perneczky, R. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-60676-6_126
“Im Gegensatz zur Aβ-Plaquepathologie findet sich pathologisch verändertes Tau-Protein zu Beginn der Alzheimer-Krankheit v. a. im entorhinalen Kortex, von wo es sich über das limbische System bis in den Neokortex ausbreitet (Braak und Braak 1997).”
Background
Moving in Semantic Space in Prodromal and Very Early Alzheimer's Disease : A Characterisation of the Semantic Fluency Task
Saranpää, A. (2020) · Työväentutkimus Vuosikirja
Combining ADAS-Cog Assessment with Hypometabolic Region of 18F-FDG PET/CT Brain Imaging for Alzheimer's Disease Detection
Aziz, S. A. A., Saripan, M. I., Ibrahim, N., Saad, F. F. A., Suppiah, S., Ismail, S. I. F., & Razali, R. M. (2021) · IEEE-EMBS Conference on Biomedical Engineering and Sciences · doi:10.1109/iecbes48179.2021.9398848
Anti-amyloid Antibodies as Probes of Amyloid Fibril Structure.
Huff, I. J. (2005)
Apport de l'analyse multidisciplinaire dans la compréhension des mécanismes physiopathologiques des démences
Deramecourt, V. (2009) · HAL
N-truncated Aβ4-x peptides in Alzheimer's disease: generation, degradation, and relationship with neuropathological hallmarks
Zampar, S. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9004
Etude multimodale de la maladie d'Alzheimer : forme sporadique prodromale, formes génétiques, et altération du traitement visuel
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Alzheimer-Demenz und andere degenerative Demenzen
Förstl, H., Bickel, H., & Perneczky, R. (2018) · Springer eBooks · doi:10.1007/978-3-662-44768-0_126-1
Demenzen
Förstl, H., Bickel, H., Perneczky, R., Hüll, M., & Daffertshofer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-16920-5_40
Alzheimer's Disease
Greicius, M. D., Rosen, H. J., & Miller, B. L. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/00373-7
Polypathology and Dementia After Brain Trauma: Does Brain Injury Trigger Distinct Neurodegenerative Diseases, or Should They Be Classified Together as Traumatic Encephalopathy?
Washington, P. M., Villapol, S., & Burns, M. P. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139696432.015
Reduced PIN1 gene expression in neocortical and limbic brain regions in female Alzheimer’s patients correlates with cognitive and neuropathological phenotypesPreprint
de Ávila, C., Suazo, C., Nolz, J., Cochran, J. N., Wang, Q., Velázquez, R., Dammer, E. B., Readhead, B., & Mastroeni, D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.553279
“DISCUSSION: 368 Imaging [43, 44], cognitive assessment [45, 46], recent peripheral evidence [47], and 369 neuropathological data [48, 49] have established that Alzheimer’s disease affects the brain for 370”
Background
Life review therapy in the elderly with Alzheimer's dementia
Aslan, A., & Diniari, N. K. S. (2023) · International journal of health & medical sciences · doi:10.21744/ijhms.v6n4.2230
Pathological chronology and pathological biochemistry: The beginning of the beginning
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00022-x
Evaluation of cognitive performance within the disease course of Alzheimer´s
Rettenwander, L. A. E. (2014) · Utrecht University Repository (Utrecht University)
Additional file 1 of Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
Luckett, E. S., Zielonka, M., Kordjani, A., Schaeverbeke, J. M., Adamczuk, K., Meyer, S. D., Van Laere, K., Dupont, P. J., Cleynen, I., & Vandenberghe, R. R. (2023) · Figshare · doi:10.6084/m9.figshare.23672601
Additional file 2 of Longitudinal APOE4- and amyloid-dependent changes in the blood transcriptome in cognitively intact older adults
Luckett, E. S., Zielonka, M., Kordjani, A., Schaeverbeke, J. M., Adamczuk, K., Meyer, S. D., Van Laere, K., Dupont, P. J., Cleynen, I., & Vandenberghe, R. R. (2023) · Figshare · doi:10.6084/m9.figshare.23672604
Réorganisation des systèmes anatomo-fonctionnels et de la topologie cérébrale entre les formes à début précoce et tardif de maladie d'Alzheimer. : approche comportementale et en IRMf de repos
Gour, N. (2013) · theses.fr (ABES) · doi:10.70675/ae7413f4z289fz49bez93c4zc085fb1b9c34
Studies on the Role of Cellular Heparan Sulfate on Tau Pathology in Alzheimer's Disease and Related Tauopathies
Sepulveda-Diaz, J. E. (2013) · theses.fr (ABES) · doi:10.70675/56c42bcbz41dfz432bzbb78z77110b373285

Authors: Braak, H., & Braak, E.
Affiliations: Goethe University Frankfurt (DE)
Corresponding author: Braak, H
ORCID: Braak, H
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 1997-07
Volume: 18
Issue: 4
Pages: S85-S88
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/s0197-4580(97)00062-6
OpenAlex: W2015001118
Cited by: 410
References: 39
Citations by year: 2026: 9 · 2025: 9 · 2024: 9 · 2023: 21 · 2022: 7 · 2021: 16 · 2020: 20 · 2019: 13 · 2018: 20 · 2017: 12 · 2016: 16 · 2015: 21 · 2014: 16 · 2013: 22 · 2012: 25
FWCI: 1.62
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, neuropathologic diagnosis, neurofibrillary tangles, neuropil threads, amyloid plaques, silver staining, Lewy body disease, brain aging
MeSH terms: Aged, Aging, Alzheimer Disease, Brain, Humans, Severity of Illness Index, Neurofibrillary Tangles, Disease Progression, Neuropil Threads, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Diagnostic Criteria for Neuropathologic Assessment of Alzheimer’s Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks